← Leaderboards
Andrew Scott Little
University Of Arizona
$3,635,068
Attributed
$7,270,136
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2023–25$5M$3.8M$2.5M$1.3M$0
'23
'24
'25
Funding mix
By agency
NIH$7,270,136 · 3
By mechanism
R01$4,431,270 · 2
RC2$2,838,866 · 1
Top collaborators
- Yana Zavros7 shared
Others in their field
Other Rising Stars on “Malignant Neoplasms”
- David Annett · Information Management Services, Inc.$35,571,865
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jon White · Midwest Research Institute$17,594,074
- Carolina Porras · Fundacion Inciensa$10,814,023
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
Research focus
Malignant NeoplasmsNeuroendocrine TumorsEndocrine System DiseasesHydrocortisoneMedicalMortality RiskDiabetes MellitusEffective TherapyFundingHormone SecretionDisease RemissionChronicCorticotropinMental DepressionAdrenal GlandsCardiovascular DiseasesAnxietyDrug ScreeningArizonaExposure ToAccelerationCellsDiagnosisNeurologic
Grant awards (7)
Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids$3,162,826
R01 · FY2025 · DK
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease$426,428
R01 · FY2025 · DK
The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT)$2,819,349
RC2 · FY2024 · DK
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease$302,700
R01 · FY2024 · DK
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease$99,542
R01 · FY2024 · DK
The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT)$19,517
RC2 · FY2024 · DK
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease$439,774
R01 · FY2023 · DK